144 related articles for article (PubMed ID: 37078933)
21. De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations.
Nasser-Ghodsi N; Mara K; Watt KD
Hepatology; 2021 Aug; 74(2):1003-1013. PubMed ID: 33544906
[TBL] [Abstract][Full Text] [Related]
22. State ranks of incident cancer burden due to overweight and obesity in the United States, 2003.
Chang S; Mâsse LC; Moser RP; Dodd KW; Arganaraz F; Fuemmler BF; Jemal A
Obesity (Silver Spring); 2008 Jul; 16(7):1636-50. PubMed ID: 18421271
[TBL] [Abstract][Full Text] [Related]
23. [Hepatocellular carcinoma: Increase in incidence or future plague?].
Raoul JL; Raimbourg J; Hiret S; Adhoute X; Senellart H
Bull Cancer; 2018 May; 105(5):502-507. PubMed ID: 29567280
[TBL] [Abstract][Full Text] [Related]
24. Diabetes mellitus and the risk of gastrointestinal cancer in women compared with men: a meta-analysis of cohort studies.
Fang HJ; Shan SB; Zhou YH; Zhong LY
BMC Cancer; 2018 Apr; 18(1):422. PubMed ID: 29661174
[TBL] [Abstract][Full Text] [Related]
25. Factors Associated With Geographic Disparities in Gastrointestinal Cancer Mortality in the United States.
Ma C; Congly SE; Chyou DE; Ross-Driscoll K; Forbes N; Tsang ES; Sussman DA; Goldberg DS
Gastroenterology; 2022 Aug; 163(2):437-448.e1. PubMed ID: 35483444
[TBL] [Abstract][Full Text] [Related]
26. Pandemic-Related Changes in Incidence and Mortality Rates of Gastrointestinal Cancers During 2020.
Murphy CC; Tavakkoli A; Wani S; Singal AG
Am J Gastroenterol; 2024 Feb; 119(2):382-387. PubMed ID: 37791616
[TBL] [Abstract][Full Text] [Related]
27. Obesity, fatty liver and liver cancer.
Qian Y; Fan JG
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):173-7. PubMed ID: 15908310
[TBL] [Abstract][Full Text] [Related]
28. Epidemiological Trends of GI Cancers in Patients Visiting a Tertiary Care Hospital in Chandigarh, North India.
Sharma MK; Singh T; Pandey AK; Kankaria A
Asian Pac J Cancer Prev; 2015; 16(8):3499-503. PubMed ID: 25921168
[TBL] [Abstract][Full Text] [Related]
29. Rising incidence of hepatocellular carcinoma in the United States.
El-Serag HB; Mason AC
N Engl J Med; 1999 Mar; 340(10):745-50. PubMed ID: 10072408
[TBL] [Abstract][Full Text] [Related]
30. Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma.
Noureddin M; Rinella ME
Clin Liver Dis; 2015 May; 19(2):361-79. PubMed ID: 25921668
[TBL] [Abstract][Full Text] [Related]
31. Obesity as a cause of hepatocellular carcinoma.
Kew MC
Ann Hepatol; 2015; 14(3):299-303. PubMed ID: 25864208
[TBL] [Abstract][Full Text] [Related]
32. Obesity and Liver Cancer in Japan: A Comprehensive Review.
Nishikawa H; Fukunishi S; Asai A; Nishiguchi S; Higuchi K
Anticancer Res; 2021 May; 41(5):2227-2237. PubMed ID: 33952449
[TBL] [Abstract][Full Text] [Related]
33. Future development of gastrointestinal cancer incidence and mortality rates in Switzerland: a tumour registry- and population-based projection up to 2030.
Joliat GR; Hahnloser D; Demartines N; Schäfer M
Swiss Med Wkly; 2015; 145():w14188. PubMed ID: 26376322
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of hepatocellular carcinoma: consider the population.
Mittal S; El-Serag HB
J Clin Gastroenterol; 2013 Jul; 47 Suppl(0):S2-6. PubMed ID: 23632345
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study.
Trichopoulos D; Bamia C; Lagiou P; Fedirko V; Trepo E; Jenab M; Pischon T; Nöthlings U; Overved K; Tjønneland A; Outzen M; Clavel-Chapelon F; Kaaks R; Lukanova A; Boeing H; Aleksandrova K; Benetou V; Zylis D; Palli D; Pala V; Panico S; Tumino R; Sacerdote C; Bueno-De-Mesquita HB; Van Kranen HJ; Peeters PH; Lund E; Quirós JR; González CA; Sanchez Perez MJ; Navarro C; Dorronsoro M; Barricarte A; Lindkvist B; Regnér S; Werner M; Hallmans G; Khaw KT; Wareham N; Key T; Romieu I; Chuang SC; Murphy N; Boffetta P; Trichopoulou A; Riboli E
J Natl Cancer Inst; 2011 Nov; 103(22):1686-95. PubMed ID: 22021666
[TBL] [Abstract][Full Text] [Related]
36. Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence.
Saunders D; Seidel D; Allison M; Lyratzopoulos G
Aliment Pharmacol Ther; 2010 May; 31(10):1051-63. PubMed ID: 20175765
[TBL] [Abstract][Full Text] [Related]
37. A 12-year trend analysis of the incidence of gastrointestinal cancers in East Azerbaijan: last updated results of an ongoing population-based cancer registry.
Somi MH; Dolatkhah R; Sepahi S; Belalzadeh M; Naghashi S; Asghari Jafarabadi M
BMC Cancer; 2019 Aug; 19(1):782. PubMed ID: 31391032
[TBL] [Abstract][Full Text] [Related]
38. Review article: the management of hepatocellular carcinoma.
Cabrera R; Nelson DR
Aliment Pharmacol Ther; 2010 Feb; 31(4):461-76. PubMed ID: 19925500
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States.
Rich NE; Yopp AC; Singal AG; Murphy CC
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):242-248.e5. PubMed ID: 31042582
[TBL] [Abstract][Full Text] [Related]
40. Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions.
Murphy N; Jenab M; Gunter MJ
Nat Rev Gastroenterol Hepatol; 2018 Nov; 15(11):659-670. PubMed ID: 29970888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
